Tandem Extracorporeal Blood Purification/Support Therapies in Critically Ill Children: A Literature Review
View abstract on PubMed
Summary
This summary is machine-generated.Tandem extracorporeal blood purification/support therapies (EBP/STs) show promise for critically ill children but lack standardized protocols and carry risks. Further research and guidelines are needed for safe and effective use in pediatric critical care.
Area Of Science
- Pediatric Critical Care Medicine
- Extracorporeal Therapies
- Intensive Care Unit Management
Background
- Tandem extracorporeal blood purification/support therapies (EBP/STs) are increasingly utilized in pediatric intensive care units (PICUs).
- These combined therapies address complex conditions like sepsis-induced multiple organ failure and acute liver failure in critically ill children.
- Current evidence, indications, and challenges of these combined EBP/STs require thorough evaluation.
Purpose Of The Study
- To comprehensively evaluate the evidence, clinical indications, methodologies, outcomes, and challenges of tandem EBP/STs in critically ill children.
- To synthesize reported risks, benefits, and proposed protocols for tandem therapy use in PICUs.
- To identify areas for improvement in the application of these advanced therapies.
Main Methods
- Conducted a literature review of peer-reviewed articles, clinical guidelines, and existing literature.
- Included studies describing tandem EBP/ST modalities in children, such as case series, observational studies, and expert reviews.
- Excluded studies focusing solely on adult populations or single modality therapies.
Main Results
- Tandem EBP/STs offer benefits like reduced procedural downtime, optimized vascular access, and enhanced therapeutic efficiency.
- However, these therapies are often used off-label with variable clinical protocols and a lack of child-specific guidelines.
- Increased risks of complications, including hypocalcemia and hemodynamic instability, limit widespread adoption.
Conclusions
- Tandem EBP/STs represent an emerging, yet incompletely standardized, intervention in pediatric critical care.
- Potential benefits are tempered by heterogeneous protocols, off-label use, and significant complication risks.
- Developing standardized guidelines, multidisciplinary training, and multicenter registries is crucial for optimizing safe and effective use.
Related Concept Videos
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

